HealthEquity (NASDAQ:HQY) Given New $125.00 Price Target at Wells Fargo & Company

HealthEquity (NASDAQ:HQY) had its price objective lifted by Wells Fargo & Company from $110.00 to $125.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Other analysts have also issued research reports about the company. BTIG Research raised their price target on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Barrington Research raised their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. The Goldman Sachs Group began coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target on the stock. Bank of America raised their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Finally, Mizuho assumed coverage on HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective on the stock. One research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $113.54.

HealthEquity Stock Performance

Shares of NASDAQ:HQY opened at $105.61 on Wednesday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a 50-day moving average price of $104.59 and a 200-day moving average price of $92.98. The company has a market cap of $9.15 billion, a price-to-earnings ratio of 96.89, a price-to-earnings-growth ratio of 1.60 and a beta of 0.55. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the prior year, the business posted $0.40 EPS. As a group, equities analysts anticipate that HealthEquity will post 2.32 EPS for the current year.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 39,000 shares of company stock valued at $3,895,788 in the last 90 days. Corporate insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Institutional investors and hedge funds have recently modified their holdings of the company. Arcadia Investment Management Corp MI bought a new position in HealthEquity in the fourth quarter valued at about $26,000. Transce3nd LLC bought a new position in shares of HealthEquity in the 4th quarter worth approximately $29,000. Smartleaf Asset Management LLC lifted its stake in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after purchasing an additional 98 shares during the period. UMB Bank n.a. boosted its holdings in shares of HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after buying an additional 164 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ grew its position in HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company’s stock valued at $45,000 after buying an additional 445 shares during the period. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.